Table 3.
The comparison between low- and high-risk groups based on SBQ
Variables | Low-Risk Group | Moderate-to-Severe-Risk Group | P |
---|---|---|---|
Sex, n (%) | |||
Female | 116 (81.7) | 53 (45.3) | <0.001 |
Male | 26 (18.3) | 64 (54.7) | |
Age (years), mean±SD | 38.74±16.43 | 59.12±13.96 | <0.001 |
Diseases, n (%) | <0.001 | ||
No disease | 93 (65.5) | 32 (27.8) | |
Other chronic diseases | 49 (34.5) | 83 (72.2) | |
BMI (kg/m2), mean±SD | 24.81±4.35 | 29.08±5.37 | <0.001 |
Neck size, n (%) | <0.001 | ||
Less than 40 cm | 129 (90.8) | 72 (61.5) | |
More than 40 cm | 13 (9.2) | 45 (38.5) | |
Types of DM, n (%) | <0.001 | ||
T1DM | 85 (59.9) | 15 (12.8) | |
T2DM | 57 (40.1) | 102 (87.2) | |
BQ status, mean±SD | <0.001 | ||
Low risk | 126 (88.7) | 33 (28.2) | |
High risk | 16 (11.3) | 84 (71.8) | |
Medications, mean±SD | <0.001 | ||
Oral agent | 44 (31) | 75 (64.1) | |
Insulin | 98 (69) | 42 (35.9) | |
FBS, mean±SD | 137.20±49.47 | 153.81±61.63 | 0.019 |
HbA1c, mean±SD | 7.48±1.52 | 7.89±1.74 | 0.046 |
HbA1c status, mean±SD | 0.110 | ||
Poor control | 73 (51.8) | 48 (41.7) | |
Good control | 68 (48.2) | 67 (58.3) |